One case of Stevens-Johnson syndrome was reported as a serious adverse event in a patient receiving aprepitant with cancer chemotherapy.
31 Ühel patsiendil, kes sai aprepitanti koos vähivastase keemiaraviga, kirjeldati raske kõrvaltoimena Stevens- Johnsoni sündroomi.